Difference between revisions of "Spebrutinib (CC-292)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Investigational" to "Category:Investigational drugs") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapy" to "Category:Chemotherapeutic") |
||
| Line 6: | Line 6: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| − | [[Category: | + | [[Category:Chemotherapeutic]] |
[[Category:Kinase inhibitors]] | [[Category:Kinase inhibitors]] | ||
Revision as of 17:56, 3 February 2019
Mechanism of action
Bruton's tyrosine kinase (BTK) inhibitor
Also known as
- Code names: AVL-292, CC-292